Terumo Yamaguchi Corporation
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Japan
- Registered address
- 3-22, SAYAMA, YAMAGUCHI, YAMAGUCHI 754-0894, Japan (JPN)
- Operations here
- analysismanufacture
- FDA identifiers
- FEI 3013611763 · DUNS 691580994
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2023-03-30
Drugs this plant is listed as making
1 distinct drugs across 2 products name this site in their FDA label.
- adalimumab-fkjpBiocon Biologics Inc
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.